Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Peng Li

4PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Nov 10, 2020
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells.

Zhiwu Jiang, Rui Liao, Jiang Lv

|Jun 10, 2020
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth.

Le Qin, Ruocong Zhao, Dongmei Chen

|Feb 04, 2020
PSCA is a target of chimeric antigen receptor T cells in gastric cancer.

Di Wu, Jiang Lv, Ruocong Zhao

|Aug 30, 2019
Mesothelin as a biomarker for targeted therapy.

Jiang Lv, Peng Li

Pageof 1

Frequent Collaborators

1 joint publications

Qifa Liu

1 joint publications

Peilong Lai

1 joint publications

Xin Du

1 joint publications

Robert Weinkove

1 joint publications

Duanqing Pei

1 joint publications

Yao Yao

1 joint publications

Peng Li

Frequent Collaborators

1 joint publications

Qifa Liu

1 joint publications

Peilong Lai

1 joint publications

Xin Du

1 joint publications

Robert Weinkove

Top Related Videos

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on : Dec 17, 2019

15.6K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

945
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

1.2K
See more related videos

Top Related Videos

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on : Dec 17, 2019

15.6K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

945
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

1.2K
See more related videos